Identification of tumor rejection antigens and the immunologic landscape of medulloblastoma.
Changlin YangVrunda TrivediKyle DysonTongjun GuKate M CandelarioOleg YegorovDuane A MitchellPublished in: Genome medicine (2024)
Using a custom antigen prediction pipeline, we identified potential tumor rejection antigens with important implications for the development of immunotherapy for medulloblastoma.